Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Share Capital (Tables)

v3.21.2
Share Capital (Tables)
 6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Schedule of shares issued granted options
    Six months ended June 30, 2021  
    Number
of options
granted		     Exercise
price
range		     Vesting
period		     Expiration  
Employees     76,500       $12.78- 13.08       4 years       10 years  
Directors    
-
       -       -       -  

 

    Six months ended June 30, 2020  
    Number
of options
granted		     Exercise
price
range		     Vesting
period
range		     Expiration  
Employees     317,909     $ 10.08       4 years       10 years  
Directors     162,713     $ 11.06       4 years       10 years  

 
Schedule of fair value options granted
    Six months ended
June 30		  
    2021     2020  
Value of ordinary share   $ 11.9-$13.93     $ 9.99-$10.5  
Dividend yield     0 %     0 %
Expected volatility     65.36%-66.49 %     66.05%-66.41 %
Risk-free interest rate     0.64%-1.06 %     0.29%-0.35 %
Expected term     6.11 years       6.11 years  

 
Schedule of the number of options granted to employees under the option plan
    Number of
options		     Weighted
average
exercise
price		  
Options outstanding at the beginning of the period     1,198,777     $ 6.88  
Granted     76,500       12.96  
Exercised     (27,152 )     4.32  
Expired    
-
      
-
  
Forfeited     (5,450 )     11.18  
Options outstanding at the end of the year     1,242,675     $ 7.46  
Options exercisable at the end of the year     645,942     $ 5.56  

 
Schedule of the number of options granted to non- employees under the option plan
    Number of
options		     Weighted
average
exercise
price		  
Options outstanding at the beginning of the period     18,082     $ 17.97  
Granted    
-
      
-
  
Exercised    
-
      
-
  
Expired     (2,666 )     64.61  
Forfeited    
-
      
-
  
Options outstanding at the end of the year     15,416     $ 2.19  
Options exercisable at the end of the year     3,750     $ 6.75  

 
Schedule of share-based compensation
    Six months ended
June 30		     Three months ended
June 30		  
    2021     2020     2021     2020  
    U.S. dollars in thousands     U.S. dollars in thousands  
Cost of revenue   $ 42     $ 22     $ 18     $
-
  
Research and development     378       215       219       152  
General, administrative and marketing     542       557       246       325  
    $ 962     $ 794     $ 483     $ 477